Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE, 1987. Human infection with Ehrlichia canis, a leukocytic Rickettsia.N Engl J Med 316 :853ā856.
-
2
Dumler JS, Madigan J, Pusteria N, Bakken J, 2007. Ehrlichiosis in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 45 :S45āS51.
-
3
Calic S, Galvao M, Bacellar F, Rocha C, Mafra C, Leite R, Walker D, 2004. Human ehrlichiosis in Brazil: first suspect cases. Braz J Infect Dis 8 :259ā262.
-
4
Ripoll CM, Remondegui CE, Ordonez G, Arazamendi R, Fusaro H, Hyman MJ, Paddock CD, Zaki SR, Olson JG, Santos-Buch CA, 1999. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg 61 :350ā354.
-
5
Lopez J, Rivera M, Concha JC, Gatica S, Loeffeholz M, Barriga O, 2003. Ehrlichiosis humana en Chile: evidencia seroloĢgica. Rev Med Chil 131 :67ā70.
-
6
Perez M, Rikihisa Y, Wen B, 1996. Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol 34 :2133ā2139.
-
7
MartiĢnez MC, GutieĢrrez CN, Monger F, Ruiz J, Watts A, Mijares VM, Rojas MG, Triana-Alonso FJ, 2008. Ehrlichia chaffeensis in child, Venezuela. Emerg Infect Dis 14 :519ā520.
-
8
Vinasco J, Li O, Alvarado A, Diaz D, Hoyos L, Tabachi L, Sirigireddy K, Ferguson C, Moro MH, 2007. Molecular evidence of a new strain of Ehrlichia canis from South America. J Clin Microbiol 45 :2716ā2719.
-
9
Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y, 2006. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann N Y Acad Sci 1078 :110ā117.
-
10
GongoĢra-Biachi RA, Zavala-VelaĢzquez J, Castro-Sansores CJ, GonzaĢlez-MartiĢnez P, 1999. First case of human ehrlichiosis in Mexico. Emerg Infect Dis 5 :481.
-
11
Machado RZ, Duarte JM, Dagnone AS, SzaboĢ MP, 2006. Detection of Ehrlichia chaffeensis in Brazilian marsh deer (Blastocerus dichotomus). Vet Parasitol 30 :262ā266.
-
12
Paddock CD, Childs JE, 2003. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 16 :37ā64.
-
13
Schoeler GB, MoroĢn C, Richards A, Blair PJ, Olson JG, 2005. Human spotted fever rickettsial infections. Emerg Infect Dis 11 :622ā624.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 23 | 23 | 6 |
| Full Text Views | 276 | 88 | 0 |
| PDF Downloads | 62 | 14 | 0 |
Serologic Evidence of Human Ehrlichiosis in Peru
Pedro L. Moro
Pedro L. Moro
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Pedro L. Moro in
Current site
Google Scholar
PubMed
Search for other papers by Pedro L. Moro in
Current site
Google Scholar
PubMed
Jyotsna Shah
Jyotsna Shah
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Jyotsna Shah in
Current site
Google Scholar
PubMed
Search for other papers by Jyotsna Shah in
Current site
Google Scholar
PubMed
Olga Li
Olga Li
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Olga Li in
Current site
Google Scholar
PubMed
Search for other papers by Olga Li in
Current site
Google Scholar
PubMed
Robert H. Gilman
Robert H. Gilman
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Nick Harris
Nick Harris
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Nick Harris in
Current site
Google Scholar
PubMed
Search for other papers by Nick Harris in
Current site
Google Scholar
PubMed
Manuel H. Moro
Manuel H. Moro
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia; IGeneX Inc., Palo Alto, California; Laboratory of Clinical Pathology, College of Veterinary Medicine, University of San Marcos, Lima, Peru; Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland; Division of Comparative Medicine, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
Search for other papers by Manuel H. Moro in
Current site
Google Scholar
PubMed
Search for other papers by Manuel H. Moro in
Current site
Google Scholar
PubMed
A serosurvey for human ehrlichiosis caused by Ehrlichia chaffeensis and Anaplasma phagocytophilum was performed in different regions of Peru by using indirect immunofluorescence assays (IFAs). Regions included an urban community in a shantytown in Lima (Pampas) and three rural communities located on the northern coast of Peru (Cura Mori), in the southern Peruvian Andes (Cochapata), and in the Peruvian jungle region (Santo Tomas). An overall E. chaffeensis seroprevalence of 13% (21 of 160) was found by IFA. Seroprevalences in females and males was 15% (16 of 106) and 9% (5 of 53), respectively. Seroprevalences in Cura Mori, Cochapata, Pampas, and Santo Tomas were 25% (10 of 40), 23% (9 of 40), 3% (1 of 40), and 3% (1 of 40), respectively. Seroprevalences in Cura Mori and Cochapata were significantly higher than in Santo Tomas or Pampas (P < 0.01). No sera were reactive to A. phagocytophilum. These findings suggest that human infection with E. chaffeensis occurs in Peru. Further studies are needed to characterize Ehrlichia species in Peru, their vectors and their clinical significance.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE, 1987. Human infection with Ehrlichia canis, a leukocytic Rickettsia.N Engl J Med 316 :853ā856.
-
2
Dumler JS, Madigan J, Pusteria N, Bakken J, 2007. Ehrlichiosis in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 45 :S45āS51.
-
3
Calic S, Galvao M, Bacellar F, Rocha C, Mafra C, Leite R, Walker D, 2004. Human ehrlichiosis in Brazil: first suspect cases. Braz J Infect Dis 8 :259ā262.
-
4
Ripoll CM, Remondegui CE, Ordonez G, Arazamendi R, Fusaro H, Hyman MJ, Paddock CD, Zaki SR, Olson JG, Santos-Buch CA, 1999. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg 61 :350ā354.
-
5
Lopez J, Rivera M, Concha JC, Gatica S, Loeffeholz M, Barriga O, 2003. Ehrlichiosis humana en Chile: evidencia seroloĢgica. Rev Med Chil 131 :67ā70.
-
6
Perez M, Rikihisa Y, Wen B, 1996. Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol 34 :2133ā2139.
-
7
MartiĢnez MC, GutieĢrrez CN, Monger F, Ruiz J, Watts A, Mijares VM, Rojas MG, Triana-Alonso FJ, 2008. Ehrlichia chaffeensis in child, Venezuela. Emerg Infect Dis 14 :519ā520.
-
8
Vinasco J, Li O, Alvarado A, Diaz D, Hoyos L, Tabachi L, Sirigireddy K, Ferguson C, Moro MH, 2007. Molecular evidence of a new strain of Ehrlichia canis from South America. J Clin Microbiol 45 :2716ā2719.
-
9
Perez M, Bodor M, Zhang C, Xiong Q, Rikihisa Y, 2006. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann N Y Acad Sci 1078 :110ā117.
-
10
GongoĢra-Biachi RA, Zavala-VelaĢzquez J, Castro-Sansores CJ, GonzaĢlez-MartiĢnez P, 1999. First case of human ehrlichiosis in Mexico. Emerg Infect Dis 5 :481.
-
11
Machado RZ, Duarte JM, Dagnone AS, SzaboĢ MP, 2006. Detection of Ehrlichia chaffeensis in Brazilian marsh deer (Blastocerus dichotomus). Vet Parasitol 30 :262ā266.
-
12
Paddock CD, Childs JE, 2003. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 16 :37ā64.
-
13
Schoeler GB, MoroĢn C, Richards A, Blair PJ, Olson JG, 2005. Human spotted fever rickettsial infections. Emerg Infect Dis 11 :622ā624.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 23 | 23 | 6 |
| Full Text Views | 276 | 88 | 0 |
| PDF Downloads | 62 | 14 | 0 |